November 20 - 22, 2013
The “global burden of disease 2010” published in December 2012 states an overall increasingly better control of infectious diseases compared to 1990. Nevertheless, in low-income countries, infectious diseases are still the leading cause of death. Today, 1.4 billion people are affected by so-called neglected tropical diseases - infections that persist in people and communities living in poverty and social exclusion. In addition, the frightening emergence of antibiotic-resistant bacteria also in the developed world and their rapid spread worldwide emphasizes the urgent need for novel therapeutics.
The goal of the Collaborative Research Center 630 (SFB 630) is to develop anti-infective drugs in an academic environment. The International Symposia, two of which were already well-received in 2006 and 2009, are a platform dedicated to bring international leading experts of all fields relevant for the development of novel anti-infectives together to discuss the latest developments, exchange ideas and plan fruitful collaborations.
In line with the versatile aspects of anti-infective drug development, the topics covered by the symposium are rather diversified and of highly interdisciplinary character. We will have sessions given by internationally renowned speakers from medicinal chemistry, natural products chemistry, microbiology, and from theoretical and physical chemistry in order to raise vivid discussions and to create a stimulating scientific atmosphere. Beside the invited talks, additional oral presentations will be selected from submitted abstracts. Also the poster session allows especially our young investigators to contribute to the ongoing discussion.
This symposium is generously supported by the German Research Foundation (DFG).
We believe that this meeting is a chance that should not be missed for all scientists involved in anti-infective research and we are looking forward to a successful and enjoyable symposium.